Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors Among 46,712 patients who received targeted therapies, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results